The effect of daily low-dose aspirin versus placebo on the progression of age-related hearing loss in healthy older adults.
HRSA pushes back against another 340B rebate model, this time from Sanofi
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS